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Abstract
Ebola Virus Disease (EVD) is a severe, often fatal illness in humans caused by the Ebola 
virus. Since the first case was identified in 1976, there have been 36 documented out-
breaks with the worst and most publicized recorded in 2014 which ravaged three West 
African Countries, Guinea, Liberia and Serial Leone. The West African outbreak recorded 
28,616 human cases, 11,310 deaths (CFR: 57–59%) and left about 17,000 survivors, many 
of whom have to grapple with Post-Ebola syndrome. Historically, ZEBOV has the highest 
virulence. Providing a historical perspective which highlights key challenges and prog-
ress made toward detecting and responding to EVD is a key to charting a path towards 
stronger resilience against the disease. There have been remarkable shifts in diagnostics, 
at risk populations, impact on health systems and response approaches. The health sector 
continues to gain global experiences about EVD which has shaped preparedness, preven-
tion, detection, diagnostics, response, and recovery strategies. This has brought about the 
need for stronger collaboration between international organizations and seemingly Ebola 
endemic countries in the areas of improving disease surveillance, strengthening health 
systems, development and establishment of early warning systems, improving the capac-
ity of local laboratories and trainings for health workers.
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1. Introduction
Ebola Virus Disease (EVD), formerly known as Ebola Hemorrhagic Fever (EHF) is a severe, 
often fatal illness in humans [1]. It has become well known and notified disease all over the 
world, since its last outbreak in Guinea, Sierra Leone and Liberia (December 2013). EVD is 
caused by the Ebola virus and is responsible for about 50–90% death in clinically diagnosed 
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cases [2]. Efforts to contain this disease have been the focus of the World Health Organization 
(WHO) and some other countries in recent times. Despite these efforts, no medicine has yet 
been licensed for the treatment of the disease [3]. The Ebola virus was first discovered in Zaire 
now called the Democratic Republic of Congo (DRC). The virus was named Ebola follow-
ing the first outbreak in the town of Yambuku, which is near the Ebola River in DRC; it is at 
the hospital in this town that the first case of Ebola was identified in September 1976 by the 
Belgian doctor Peter Piot of the Institute of Tropical Medicine Anvers [4, 5]. This study aims 
to summarize old and new experiences of Ebola all over the world, in order to have an over-
view of all Ebola outbreaks and to propose strategies for better prevention and management 
of future outbreaks.
1.1. Etiology
The Ebola virus (EBOV) is the principal etiology of EVD [6], Ebola virus belongs to the fam-
ily of Filoviridae, to the order of Mononegavirales which includes Rhabdoviridae and 
Paramyxoviridae. The virion is pleomorphic, producing “U”-shaped, “6”-shaped, or circular 
forms but the predominant forms of the virion most frequently seen by electron microscope are 
long tubular structures. It contains one molecule of linear, single-stranded, negative-sense RNA 
of 4.2 × 106 Da [7]. EVD is caused by five genetically distinct members of the Filoviridae family:
1. Zaire ebolavirus (ZEBOV): Up to 2000, Ebola virus (EBOV) was formerly designated by 
Zaire Ebola virus [8, 9]. And in 2002, to species Zaire ebolavirus [10, 11]. However, most sci-
entific articles continued to refer to “Ebola virus” or used the terms Ebola virus and Zaire 
ebolavirus in parallel. Consequently, in 2010, a group of researchers recommended that the 
name “Ebola virus” be adopted for a subclassification within the species Zaire ebolavirus, 
with the corresponding abbreviation EBOV [12]. Previous abbreviations for the virus were 
EBOV-Z (for Ebola virus Zaire) and ZEBOV (for Zaire Ebola virus or Zaire ebolavirus). At 
present, ICTV does not officially recognize “Ebola virus” as a taxonomic rank, and rather 
continues to use and recommend only the species designation Zaire ebolavirus [13].
2. Sudan ebolavirus (SEBOV): Sudan virus was first introduced as a new “strain” of Ebola vi-
rus in 1977 [14]. Sudan virus was described as “Ebola haemorrhagic fever” in a 1978 WHO 
report describing the 1976 Sudan Ebola outbreak [15]. In 2000, it received the designation 
of Sudan Ebola virus [8, 9], and in 2002 the name was changed to Sudan ebolavirus [10, 
11]. Previous abbreviations for the virus were EBOV-S (for Ebola virus Sudan) and most 
recently SEBOV (for Sudan Ebola virus or Sudan ebolavirus). The virus received its final 
designation in 2010, when it was renamed Sudan virus (SUDV) [12].
3. Côte d’Ivoire ebolavirus (CEBOV): The name Taï Forest ebolavirus is derived from Parc 
National de Taï (the name of a national park in Côte d’Ivoire, where Taï Forest virus was 
first discovered) and the taxonomic suffix ebolavirus (which denotes an ebolavirus spe-
cies) [12]. Taï Forest virus was first introduced as a new “strain” of Ebola virus in 1995 
[16]. In 2000, it received the designation Côte d’Ivoire Ebola virus [8, 9]. In 2002, the name 
was changed to Cote d’Ivoire ebolavirus [10, 11]. The virus received its final designation in 
2010, when it was renamed Taï Forest virus (TAFV) [12].
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4. Bundibugyo ebolavirus (BEBOV): Bundibugyo virus was first introduced as Bundibugyo 
ebolavirus in 2008 [16]. The name Bundibugyo virus is derived from Bundibugyo (the name 
of the chief town of the Ugandan Bundibugyo District, where it was first discovered) and 
the taxonomic suffix virus [12]. Another name introduced at the same time was Uganda 
ebolavirus [17]. Later publications also referred to the virus as a novel “strain” of Ebola 
virus [18], or as Bundibugyo Ebola virus [19]. The abbreviations BEBOV (for Bundibugyo 
ebolavirus) and UEBOV (for Uganda ebolavirus) [17], were briefly used before BDBV was 
established as the abbreviation for Bundibugyo virus [12].
5. Reston ebolavirus (REBOV): Reston virus was first introduced as a new “strain” of Ebola 
virus in 1990 [20]. In 2000, it received the designation Reston Ebola virus [26, 27], and in 
2002 the name was changed to Reston ebolavirus [8, 9]. Previous abbreviations for the 
virus were EBOV-R (for Ebola virus Reston) and most recently REBOV (for Reston Ebola 
virus or Reston ebolavirus). The virus received its current designation in 2010, when it was 
renamed Reston virus (RESTV) [12].
1.2. Transmission
Transmission in most outbreaks, Ebola virus is introduced into human populations via the 
handling of infected animal carcasses. In these cases, the first source of transmission is an 
animal found dead or hunted in the forest, followed by person-to person transmission from 
index case to family members or health-care staff. Animal-to-human transmission occurs 
when people come into contact with tissues and bodily fluids of infected animals, especially 
with infected NHPs [21]. The most likely vector of the EBOV is the fruit bat, specifically 
Hypsignathus monstrosus (the hammer-headed fruit bat), Epomops franqueti (Franquet’s epau-
lets fruit bat), and Myonycteris torquata (the little-collared bat) [22].
Between 1976 and 1998, in 30,000 mammals, birds, reptiles, amphibians and arthropods 
sampled from regions of EBOV outbreaks, no Ebola virus was detected apart from some 
genetic traces found in six rodents (belonging to the species Mus setulosus and Praomys) and 
one shrew (Sylvisorex ollula) collected from the Central African Republic [23, 24]. Further 
research efforts have not confirmed rodents as a reservoir [25]. Traces of EBOV were detected 
in the carcasses of gorillas and chimpanzees during outbreaks in 2001 and 2003, which later 
became the source of human infections. The high rates of death in these species resulting 
from EBOV infection make it unlikely that these species represent a natural reservoir for 
the virus [23]. Antibodies against Zaire and Reston viruses have been found in fruit bats 
in Bangladesh, suggesting that these bats are also potential hosts of the virus and that the 
filoviruses are present in Asia [26].
The means of transmission within bat populations remain unknown [27]. Human disease is 
thought to result from consumption of poorly-cooked infected animals, such as bats or chim-
panzees (which are known to feed on bats) [22, 28]. According to the findings of the WHO in 
October 2014, the most infectious fluids are blood, feces and vomit. The virus has also been 
detected in breast milk and urine [29]. However unlike other zoonosis, Ebola has the potential 
of spreading from human to human through exposure of mucous membranes or broken skin to 
infected body fluids including large aerosol droplets that can be produced during coughing [30].
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1.3. The clinical features
The clinical features can be divided into four main phases as follows:
(Phase A) Influenza–like syndrome: The onset is abrupt with non-specific symptoms or signs 
such as high fever, headache, arthralgia, myalgia, sore throat, and malaise with nausea.
(Phase B) Acute (day 1–6): Persistent fever not responding to antimalarial drugs or to antibiotics, 
headache, and intense fatigue, followed by diarrhea and abdominal pain, anorexia and vomiting.
(Phase C) Pseudo-remission (day 7–8): During this phase the patient feels better and seeks 
food. The health situation presents with some improvement. Some patients may recover dur-
ing this phase and survive from the disease.
(Phase D) Aggravation (day 9): respiratory disorders (dyspnea, throat and chest pain, cough, 
hiccups), symptoms of hemorrhagic diathesis (bloody diarrhea, hematemesis, conjunctival 
injection, gingival bleeding, nosebleeds and bleeding at the site of injection consistent with 
disseminated intravascular coagulation), skin manifestations (petechiae, purpura, morbilli-
form skin rash), neuropsychiatric manifestations (prostration, delirium, confusion, coma) and 
cardio-vascular distress and hypovolemic shock (death) [7].
Patients do not transmit Ebola during the incubation period but become infectious once they 
develop clinical features of EVD [30]. From the clinical manifestations it is obvious that EVD 
may mimic many other tropical diseases like malaria, typhoid fever or yellow fever at the 
start of the disease. In most outbreaks, recognition of the disease is delayed because physi-
cians are not accustomed to this new illness and the symptoms are generally non-specific. 
Outside the epidemic context, it appears quite impossible to recognize the first Ebola case 
in an outbreak on clinical grounds only. Suspicion of EVD is only possible later during the 
aggravation phase [7].
2. Methodology
This study aims to summarize results of publications on all Ebola outbreaks. In order to 
accomplish this work, information was taken from databases such as PubMed and Cochrane 
library, and some articles were also taken from Google Scholar. This search will focus on past 
and present Ebola outbreaks all over the world. For some abstracts that met the predefined 
inclusion criteria, full texts were obtained. The data collection was focused more on some 
aspects of each outbreak such as: the year of the outbreak, the geographical spread (estimated 
area covered by the outbreak, country and region), and the strain of the virus involved in each 
outbreak, the index case, the case fatality, the diagnosis and the treatment used to control the 
situation. All the data will be put in Microsoft Excel software for construction of graphs. The 
data collection started on first July and ended on first August 2017; and a total of 23 full text 
and 6 abstracts were selected for the data extraction.
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3. Ebola outbreaks characteristics (1976–2017)
This section will focuses on the characteristics of all Ebola outbreaks. In total, there have 
been 36 documented Ebola outbreaks that can be grouped into two: Major/Massive cases and 
Minor/Single cases.
3.1. Major outbreaks
Major outbreaks are larger outbreaks with more than 10 human registered cases of EVD (19 
outbreaks).
The table highlights each major outbreak, the viral species responsible for the outbreak with 
the specie that induce the EVD, the country and the year in which the outbreak occurred, 
and the number of cases and deaths recorded. Table 1 shows also after the West African 
Ebola Epidemic, Uganda is the second country in terms of number of cases, it has registered 
a lot of cases of Ebola during its first outbreak of 2000–2001 (425 cases/224 deaths).
3.2. Minor outbreaks
Minor/Single cases: these are smaller outbreaks with less than 10 human cases of EVD (17 
outbreaks in total) (Table 2: minor Ebola outbreaks).
The DRC (Zaire) has recorded the highest number of EVD outbreaks (8 in total). It is also 
important to note that some of the Ebola cases were asymptomatic in minor outbreak such as 
in the Philippines 1, Philippines 3 and USA 2 outbreaks.
3.3. Case fatality rate of Ebolavirus
A case fatality rate (CFR) or case fatality risk is a property of an infectious disease in a particu-
lar population which states the risk of fatality due to the disease per case [31].
Figure 1 shows the distribution of case fatality by outbreaks (major outbreaks).
Figure 1 shows that the highest case fatality of major EVD outbreak in the all story of Ebola 
was recorded in the first outbreak in the Republic of Congo caused by ZEBOV (90%). and the 
lowest case fatality occurred in the fourth Ugandan outbreak caused by SUDV (34%). This 
corroborated with Literature that has reported Zaire species to have a higher case fatality than 
Sudan and Bundibugyo species, case fatality rates for ZEBOV as high as 90% [32].
3.4. Distribution of outbreaks by species of Ebola virus
Figure 2 shows how often each species of Ebola virus has been observed in the registered 
outbreaks. Figure 2 also shows that ZEBOV is most commonly reported specie responsible 
for Ebola outbreaks.
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3.5. The West African outbreak (December 2013–2016)
The West African EVD outbreak still and remains the most severe and largest outbreak. It has 
divested 3 principal countries: Liberia, Sierra Leone and Guinea, and spread abroad. Small out-
breaks occurred in Nigeria and Mali [33, 34], and isolated cases were recorded in Senegal [35], 
Name* Year Cases/deaths Country (city)/strain
Zaire1 August 1976 318/280 Zaire (Democratic Republic of Congo/DRC) in 
Yambuku/ZEBOV
Sudan1 November 1976 284/151 Sudan occurred in Nzara, Maridi, Tumbura and 
Juba/SUDV
Sudan2 1979 34/22 Sudan occurred in Nzara and Maridi/SUDV
Gabon1 1994 52/31 Gabon occurred in Makokou/ZEBOV
Zaire3 1995 315/254 Zaire in Kikwit/ZEBOV
Gabon2 1996 (January to April) 37/21 Gabon in Mayibout area/ZEBOV
Gabon3 1996–1997 (July to 
January)
60/45 Gabon occurred in Booue area/ZEBOV
Uganda1 2000–2001 425/224 Uganda in the Gulu, Masindi, and Mbarara 
district/SUDV
Gabon4 2001–2002 (October to 
July)
135/107 Gabon and Republic of the Congo/ZEBOV
Congo1 2002–2003(December to 
April)
143/128 Republic of Congo in the district of Mbomo and 
Kelle/ZEBOV
Congo2 2003 (November to 
December)
35/29 Republic of Congo occurred in Mbomo and 
Mbandza/ZEBOV
Sudan3 2004 17/7 Sudan in Yambio/SUDV
DRC1 2007 264/187 DRC in Kasai-Occidental province/ZEBOV
Uganda2 2007–2008 (December to 
January)
149/47 Uganda in the Bundibugyo district/BDBV
DRC2 2008–2009 (December to 
Febuary)
32/14 DRC occurred in Mweka and Luebo/ZEBOV
Uganda4 2012 (June to August) 24/17 Uganda in Kibaale district/SUDV
DRC3 2012 (June to November) 77/36 DRC in the Orientale Province/BDBV
West Africa 2013–2016 28.161/11,310 West African Ebola Virus Epidemic:
Liberia, Sierra Leone, Guinea
It began in Gueckedou (Guinea) in December 
2013
ZEBOV
DRC4 2014 (August to October) 66/49 DRC in the Equateur Province/ZEBOV
Notes: Sudan here refers to South Sudan, formerly Sudan.
*Chronological Name of outbreak with the country name as the prefix and the number of time that outbreak occurred 
in that country as the suffix.
Table 1. Major Ebola outbreaks.
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the United Kingdom and Sardinia [36, 37]. In addition, imported cases led to secondary infec-
tion of medical workers in the United States and Spain but did not spread further [38, 39].
Figure 3 shows the location of the West African Ebola outbreak.
It began in Guéckédou (Guinea) in December 2013 [41], On 25 March 2014 the WHO indi-
cated that Guinea’s Ministry of Health had reported an outbreak of Ebola virus disease in 
four southeastern districts, and that suspected cases in the neighboring countries of Liberia 
and Sierra Leone were being investigated [42], and on 29 March 2016, the WHO terminated 
the Public Health Emergency of International Concern status of the outbreak [43–45]. 28,616 
human reported cases and 11,310 human deaths were registered with a case fatality of 57–59% 
(Among hospitalized patients [46, 47]. The outbreak left about 17,000 survivors of the disease, 
many of whom report post-recovery symptoms termed post-Ebola syndrome, often severe 
enough to require medical care for months or even years [48].
Name* Year Number of reported cases/number 
of death
Country (city)/strain
UK1 1976 1 case/0 death United Kingdom/ZEBOV or SUDV
Zaire2 1977 1 case/1 death Zaire in Tandala/ZEBOV
Philippines1 1989–1990 3 cases (asymptomatic)/0 death Philippines/RESTV
USA1 1989 0 case/0 death United States/RESTV
USA2 1990 4 cases (asymptomatic)/0 death United States/RESTV
Italy1 1992 0 case/0 death Italy/RESTV
C.I 1 1994 1 case/0 death Cote d’ Ivoire in Tai National Park/TAFV
C.I 2 1995 1 case/0 death Cote d’ Ivoire
SAF1 1996 2 cases/1 death South Africa/ZEBOV
USA3 1996 0 case/0 death United States/RESTV
Philippines2 1996 0 case/0 death Philippines/RESTV
Russia1 1996 1 case/1 death Russia/ZEBOV
Phillippines3 2008 6 cases (asymptomatic)/0 death Philippines/RESTV
Uganda3 2011 1 case/1 death Uganda in Luwero district/SUDV
Uganda5 2012–2013 6 cases/3 death Uganda in Luwero district/SUDV
Phillipines4 2015 0 case/0 death Philippines/RESTV
DRC5 2017 8 cases/4 death DRC/ZEBOV
*Chronological Name of outbreak with the country name as the prefix and the number of time that outbreak occurred in 
that country as the suffix (e.g., Uganda 3 means the third outbreak in Uganda).
Notes: RESTV usually cause EVD in primates and others animals such as pigs, that why some of the outbreaks with 
RESTV as specie had 0 human cases and 0 deaths means that it was found in animals and not in human. However, Human 
being can get EVD with RESTV and not developed symptoms (that is the case of asymptomatic human cases of EVD).
Table 2. Minor Ebola outbreaks.
A Historical Review of Ebola Outbreaks
http://dx.doi.org/10.5772/intechopen.72660
9
Table 3 shows that Liberia registered a high number of Ebola cases as the number of deaths in 
the West African outbreak, however the high case fatality (in major outbreaks) was reported 
in Guinea.
It is worth noting that Nigeria was the first West African country to be declared Ebola free (20 
October 2014) [49].
Figure 1. Distribution of case fatality rate by major outbreaks.
Figure 2. Distribution of outbreaks by species of Ebola virus.
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3.6. Index cases
The index case, primary case, or patient zero is the initial patient in the population of an epi-
demiological investigation [50, 51]. The index case may indicate the source of the disease, the 
possible spread, and which reservoir holds the disease in between outbreaks. The index case 
Figure 3. West African Virus Epidemic map [40].
Country Number of cases Number of deaths Case fatality
Liberia* 10,666 4806 45%
Sierra Leone* 14,122 3955 28%
Guinea* 3804 2536 66%
Nigeria 20 8 40%
Mali 8 6 75%
USA 4 1 25%
Italy 1 0 0
UK 1 0 0
Senegal 1 0 0
Spain 1 0 0
Total 28,616 11,310
*Major West African outbreak (Guinea, Liberia and Sierra Leone).
Table 3. Distribution of reported cases by countries in West African Ebola Epidemic.
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is the first patient that indicates the existence of an outbreak. Earlier cases may be found and 
are labeled primary, secondary, tertiary, etc. [52].
In most of EVD outbreaks the index cases have to be in contact of a virus reservoir, eat an 
animal found dead or hunted in the forest, or also a traveler who was in contact with an Ebola 
case (Medical professionals for example). The index case of EVD is the point on which the 
human to human transmission starts; he is the bridge between animal and human transmis-
sion of the disease.
A Chronological list of some index cases in the history of Ebola:
1. The first recorded victim of the Ebola virus was a 44-year-old schoolteacher named Maba-
lo Lokela (in Zaire/DRC), who felt ill after eating fresh and smoked antelope and monkey; 
he died on 8 September 1976 [53].
2. In 1994 (Cote d’ Ivoire) a scientist became ill after conducting an autopsy on a wild chim-
panzee in the Tai Forest. The patient was treated in Switzerland [16].
3. In 1995 (Zaire) the index case was farming and preparing charcoal in the remnant forest 
areas of Kikwit, there were a lot of bats and rodents in the region [54].
4. In 1996 (January-April) in Mayibout area (Gabon), a chimpanzee found dead in the forest 
was eaten by people hunting for food. Nineteen people who were involved in the butchery 
of the animal became ill [55].
5. In 1996 (South Africa) a medical professional traveled from Gabon to Johannesburg, after 
having treated Ebola-infected patients and having been exposed to the virus. He was hos-
pitalized, and a nurse who took care of him became infected and died [56].
6. 1996–1997 (Gabon) Occurred in Booué area with transport of patients to Libreville. Index 
case-patient was a hunter who lived in a forest camp. Disease was spread by close contact 
with infected persons. A dead chimpanzee found in the forest at the time was determined 
to be infected [55].
7. In 2000–2001 (Uganda): a farmer in Rwot Obillo village, 14 kilometers North of Gulu town 
was the index case [57].
8. In 2007 (DRC/Zaire) In Mweka, Kasai Occidental Province. The index case was the chief of 
the village and a hunter [58].
9. In 2011 (Uganda): On the 5th of May, a 13-year-old girl was admitted to Bombo hospital, 
the Sudan Ebola subtype was detected and confirmed [59].
10. In 2012 (Uganda): The index case was a 16-year-old female from a remote rural commu-
nity. She fell sick while preparing forest land with her husband for the planting season. 
Nine relatives who participated at the funeral died including a mother, and several sisters 
who contracted the infection died [59].
11. In 2013 (West African outbreak), 2-year-old Emile Ouamouno is believed to be the index 
patient in the 2014 Ebola epidemic in Guinea and West Africa [60]. Scientists have long 
believed that bats are involved in the spread of the virus, and, incidentally, the boy’s home 
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was in the vicinity of a large colony of Angolan free-tailed bats. The Ebola virus was, how-
ever, not found in any of the bats that were captured and tested [61]. His mother, sister, 
and grandmother later became ill with similar symptoms and also died; people infected 
by these initial cases spread the disease to other villages [62, 63].
12. In 2014 (DRC/Zaire) in the Equator province, the index patient was a pregnant woman 
living in Inkanamongo village, who butchered a monkey [64].
13. 2017 (DRC/Zaire), the first patient to be seen was a 39-year-old man who reported to the 
local health facility on 22nd April 2017. He was immediately referred to Likati health zone 
facility but he died in transit. On 24th April 2017, a motorcycle rider (who transported the 
first patient) and another person who supported the first patient during transportation 
developed acute febrile illness. The motor cycle rider subsequently died on 26 April 2017. 
Other people who were close to these patients eventually developed similar illness [65].
3.7. Ebola virus in health care workers
Morbidity and mortality caused by EVD among health care workers has been very important. 
The major difference between the management of the Ebola epidemic and others, such as the 
HIV epidemic, is that the Ebola virus presents a more challenging health hazard to health care 
providers. Nurses, doctors, Red Cross volunteers, and other health care workers stand the 
risk of being infected with the Ebola virus while providing care. The risk of EVD contamina-
tion among these health care workers is also increased in a continent like Africa where the 
nurses and other health care providers work under extraordinarily difficult conditions, lack-
ing such basic infection control tools as bleach, soap, and gloves [2]. When an Ebola patient, 
comes with non-diagnosed EVD in a hospital, the chain of contamination can start with the 
health care provider that offers the first care [3].
The first and famous example of a contaminated health worker is the nurse Mayinga N’Seka, 
who died in the 1976 outbreak in Zaire (now DRC) and to whom the prototype Ebola virus 
variant Mayinga (EBOV/May) was named [66]. The 1995 Democratic Republic of the Congo 
(DRC) outbreak devastated health care workers, out of the 250 individuals who died, 47 
(approximately 20%) were health care professionals [58]. In Uganda, in the first outbreak of 
2000–2001, the were 31 health workers among victims; And in the 2007 outbreak, 14 health 
care workers were among the victims [59]. Another example is the case of a Congolese (DRC) 
doctor and three health workers, who undertook a postmortem cesarean section on the index 
case of the 2014 outbreak. Both were not only infected and died; but became the evident 
source of further transmission in this outbreak. And from that outbreak, there were 49 regis-
tered deaths, of which 8 were health care professionals [64].
In the West African outbreak, it was estimated that, depending on their occupation in the 
health service, health workers were between 21 and 32 times more likely to be infected with 
Ebola than people in the general adult population. WHO estimated that large number of 
nurses and nurse aides have been affected, accounting for more than 50% of all health worker 
infections with occupation reported. Other categories of health workers affected include med-
ical workers (doctors and medical students (12%), laboratory workers and trade and elemen-
tary workers (janitors, maintenance staff, etc.) with 7% each [67]. In a study done only in 
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Guinea in 2015, among Guinean health care workers, incidence of Ebola infection was highest 
among laboratory technicians (34.7 per 1000) and doctors (26.6 per 1000), followed by mid-
wives (8.7 per 1000) and nurses (5.5 per 1000) [68].
Many other health care workers have been contaminated while taking care of EVD patients in 
Africa and imported to other continents, thereby becoming the index cases for those countries. 
Examples are the United Kingdom (Glasgow, 2014), where a nurse coming from Sierra Leonne 
was considering a first case of Ebola to be diagnosed on British soil [69] and in USA (Texas, 
2014), a healthcare worker coming from Liberia, reportedly a female nurse at Texas Presbyterian 
Hospital was the first known person-to-person transmission case of Ebola in the US [70].
In Africa, especially in rural area, Ebola outbreaks have been linked to many rumors and leg-
ends. The existence of rumors and legends related to the outbreaks could obscure the viral 
nature of the disease [7], and this can lead to difficulty, for health workers, to easily accomplish 
their tasks. Nurses and doctors had to deal with not only a panicked and fearful public, essen-
tially absent public health and medical resources, but also they themselves were seen as agents 
of death [2]. In Kikwit (DRC), anyone associated with Ebola was likely to have experienced 
stigmatization. At a point during the outbreak, local people thought Ebola originated from the 
medical staff working in the hospital. All those who had died had been in a hospital. Therefore, 
the people reasoned that, it was the health care workers who were killing the people [2]. In 
West African countries some patients were taken to traditional healers rather than science in a 
bid to combat the disease [71, 72]; increasing then the risk of contamination in the population.
3.7.1. Example of the experience of a health worker in Ebola outbreaks
Doctor Bona Ngoyi one of the co-authors, who has provided health care to EVD patientS in 
three outbreaks: firstly in the 2014 outbreak in DRC, secondly in the West African outbreak 
in Guinea (2015) and thirdly in the last outbreak (2017) in the DRC- reported that: “the general 
objective of the mission was to provide technical support in the fight against Ebola in all outbreaks. But 
each outbreak faces different challenges. For example, when i was assigned to the prefecture of Dubréka 
in Guinea (11 March 2015 to 10 May 2015). The big challenge in this area was the management of 
EVD cases alerts; the active management of EVD was facing a lot of challenges such as: lack of good 
health care structures without standardized checklists of the cases, inadequate collaboration of certain 
families which hinder proper contact tracing activities. Thus, there were confirmed cases whose source 
cases were unknown. The mobility of cases was also a major challenge in managing this particular epi-
demic in Dubreka, patients with EVD could travel from a village to another, spreading the disease. It 
should be pointed out that our mission in Dubreka prefecture was characterized by lack of enthusiasm. 
Several times, the teams of supervisors, care teams and the Red Cross were assaulted by the villagers, 
making the task very difficult to all health workers.”
Talking about Ebola outbreaks in the DRC, he also reported that: “The management of Ebola in 
the DRC seems to be simplified by the facts that the population were a little informed about the disease, 
and rumors and legends seemed to disappear with time, because DRC has registered a high number of 
Ebola outbreaks and people are accepting to collaborate with health workers. The big challenges how-
ever have to do access the region concerned by the outbreak. These areas are often located in the Huge 
Equatorial Forest, which doesn’t have good roads and Health structures” (Figures 4 and 5).
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3.8. Treatment
There is no effective drug for EVD. Only supportive care could be administered, to sustain 
cardiac and renal functions with prudent use of perfusion. Oral rehydration can be recom-
mended but sometimes not realistic because of throat pain, vomiting and intense fatigue [7].
In a clinical experiment conducted late in the 1995 Ebola outbreak in Kikwit, human con-
valescent blood was used for passive immunization to treat patients that had been infected 
naturally with ZEBOV; seven out of eight patients, who received blood transfusion from 
convalescent Ebola patients survived [72]. Such experiments, unfortunately, have not been 
repeated in further outbreaks because in vitro studies showed that antibodies against Ebola 
had no neutralizing activities. In addition, although monoclonal antibodies to the glycopro-
tein of Ebola virus showed protective and therapeutic properties in mice, they failed to pro-
tect NHP [73, 74]. Four laboratory workers in Russia who had possible Ebola exposure were 
treated with a combination of a goat-derived anti-Ebola immunoglobulin plus recombinant 
Figure 4. Dr. Bona Ngoyi explaining hand washing techniques to the population of Boende (Equator province) during 
the 2014 Ebola outbreak in DRC.
Figure 5. Dr. Bona Ngoyi and his colleague using a boat to Likati (Equator province in DRC) to provide health care to 
the population during 2017 Ebola outbreak.
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human interferon alfa-2. One of these patients had a high-risk exposure and developed clini-
cal evidence of Ebola virus infection. All 4 patients recovered [75].
Many others Ebola vaccine candidates had been developed in the decade prior to 2014 [76]. 
In December 2016, Ebola virus disease was found to be 70–100% prevented by rVSV-ZEBOV 
vaccine, making it the first proven vaccine against the disease [77, 78].
4. Evolution of Ebola disease overtime
This section will focuses on key historical developments of Ebola disease over time.
4.1. Geographical evolution of the disease (country or regional spread)
For More than 3 decades (1976–2013), all major Ebola outbreaks were occurred in Central African 
countries: DRC, Uganda, Sudan, Congo, and Gabon. This could be linked to the Equatorial forest 
which covers all these countries: It has been shown that tropical rain forests of Africa to which 
the Western Congo Swamp Forests near Yambuku and Minkebé Forest in Gabon belong con-
stitute a common ecosystem for Ebola virus emergence providing rich animal biodiversity and 
as such epidemics appear to be seasonal. Documented human and non-human EVD outbreaks 
occurred mainly during wet seasons, marked by fruit abundance. The index case of the 1995 
EVD outbreak in Kikwit fell ill in January and the 1994 EVD outbreak among chimpanzees in the 
Tai forest occurred in November, at the end of the wet season [7]. It is also interesting to note that 
the center of outbreaks has always been in areas bordering on forests (ecotone forest-savannah 
in the Democratic Republic of Congo, savannah in Sudan) [79]. In Uganda, the regions (Luwero, 
Kibaale, Gulu) in which the outbreak occurs are areas bordering forests. The equatorial forest is a 
poorly developed region, where the population lives essentially by hunting [3]; this can increases 
contact with animals or animal’s carcasses which could be potential reservoir of the virus.
Ebola outbreaks tend to occur more in a rural areas than urban areas, while the West Africa out-
break marks the first outbreak in a densely populated urban area within Conakry’s large shanty 
towns [80]. Ebola outbreak has changed in its region of occurrence from central Africa to west-
ern African countries in 2013, and spread (isolated cases) all over the world (USA, UK, Italy). 
It is important to note that the index case in most of the outbreak comes from the rural area.
4.2. Severity evolution of the Ebola strain
Studies have shown that the high case-fatality rate for Ebola virus is attributed to Zaire Ebola 
virus species (50–90%), the case fatality for SUDV range from 40 to 60% [81, 82] and approxi-
mately 40% for BDBV [19]. Only one person has been infected with the Taï Forest strain and 
survived the illness [82, 83]. RESTV specie seems to be less pathogenic to humans. In a meta-
analysis of WHO data from 20 outbreaks involving Zaire, Sudan and Bundibugyo Ebola spe-
cies, including the 2014 West African outbreak, the average case fatality rate was estimated to 
be 65.4%, and ZEBOV case fatality was reported to decrease with time [84]. It is important to 
note that the more the country registered the outbreak, more the case fatality decrease: this 
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could be explained by the fact that the health workers of a region which has registered several 
Ebola outbreaks will be trained to contain the disease than those in other regions which have 
never experienced the disease.
Another factor that could increase the severity of Ebola in Africa could be the co-infection of 
Ebola and Malaria or with other tropical diseases. The researchers found that malaria co-infec-
tion; extremes in age and delayed healthcare seeking behavior were all associated with mor-
tality. Additionally, symptoms including disorientation, hiccups, diarrhea, and conjunctivitis, 
shortness of breath and muscle aches were all predictors of death in a very short time [85].
4.3. Changes and progress in diagnostic techniques for Ebola
Laboratory diagnosis of Ebola virus disease plays a critical role in outbreak response efforts; 
however, establishing safe and expeditious testing strategies for this high-biosafety-level 
pathogen in resource-poor environments remains extremely challenging. Since the discov-
ery of Ebola virus in 1976 via traditional viral culture techniques and electron microscopy, 
diagnostic methodologies have trended towards faster, more accurate molecular assays. 
Importantly, technological advances have been paired with increasing efforts to support 
decentralized diagnostic testing capacity that can be deployed at or near the point of patient 
care [86]. Since the West African outbreak, efforts have been done to find a rapid and safe test 
for diagnosis of Ebola.
Diagnosis of Ebola has changed from cell culture, Antibody detection, Protein Antigen detec-
tion, conventional RT-PCR to Real-time RT-PCR. Real-time RT-PCR testing is an accurate 
and high-throughput modality and has become the standard for EVD diagnosis [86]. Current 
WHO guidelines recommend initial testing with an RDT when RT-PCR testing is not imme-
diately available and to assist in triage and case management when clinical and laboratory 
resources are overwhelmed [87]. Furthermore, the requirement for collection and transport of 
venipuncture blood will continue to confer additional safety and logistical hurdles. In order to 
face these challenges, it is imperative that international partners work together with national 
health ministries to strengthen laboratory capacity in regions where Ebola is endemic, includ-
ing the development of practical improvements to pre- and post-analytic processes and the 
training of local laboratory technicians in molecular diagnostic techniques, biosafety prac-
tices, and quality control [86].
5. Cost and effectiveness of Ebola outbreaks responses
The Ebola Response is highly complex. It requires the continuous effort by hundreds 
of different kinds of organizations and thousands of people to implement it quickly, 
effectively and efficiently [88]. Many countries all over the world have put public health 
measures (National response) in place to control EVD, apart from the supportive care 
that could be administrated to patient. These measures include checking and screen-
ing for EBOV at the airports and other points of entry, quarantine of people coming 
from regions associated with Ebola, and isolation of suspected and clinically diagnosed 
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patients. The corner-stone for controlling an outbreak of EVD is to interrupt the viral 
transmission chain [7]. Management of survivors of EVD can also contributed to a good 
control of the outbreak. In the West Africa outbreak, Non-Conventional Humanitarian 
Interventions (NCHI) was declared as the principal strategy with major tasks at imple-
menting relief logistics and the much-needed public health emergency responses to 
stamp out Ebola outbreak in vulnerable populations. The NCHI successfully supported 
operational containment efforts and lessons learnt in West Africa lay the foundation for 
accountable, transparent and innovative model for emergency response to global dis-
ease outbreaks in the most remote vulnerable populations [89]. In Uganda, Psychosocial 
Support (PSS) and community based volunteers in response to Ebola disease were 
introduced and the response was perceived to be very effective [90]. Other countries, 
which had experienced Ebola outbreaks before, opted to send their trained health work-
ers to help those vulnerable regions to Ebola outbreak. For example, in August 2014 a 
team of 14 health workers from Uganda, which has “strong experience” of working 
with domestic Ebola outbreaks, had been deployed by the WHO to JFK Hospital in 
Monrovia, Liberia [91]. On 27 October 2014 it was announced that a further 30 Ugandan 
health workers were dispatched to affected countries in West Africa [92].
Various organizations around the world have always responded to all Ebola outbreaks: 
WHO, CDC, Medecins Sans Frontieres, etc. They work in collaboration or in association 
with health ministry of different countries which have been mapped out as areas with Ebola 
outbreaks. Special attention was taken to the West African outbreak. In August 2014, the 
outbreak was declared as an international public health emergency and a roadmap was 
published to guide and coordinate the international response to the outbreak, aiming to 
stop ongoing Ebola transmission worldwide within 6–9 months [93]. As of September 2014, 
a massive international response to the crisis was under way. The United Nations Mission 
for Ebola Emergency Response (UNMEER) had the task of overall planning and coordina-
tion, directing the efforts of the UN agencies, national governments, and other humanitarian 
actors to the areas where they are most needed [94]. UNMEER’s objective was to work with 
others to stop the Ebola outbreak. UNMEER worked closely with governments, regional 
and international actors, such as the African Union (AU) and the Economic Community of 
West African States (ECOWAS), and with UN Member States, the private sector and civil 
society. Accra, in Ghana, served as a base for UNMEER, with teams in Guinea, Liberia and 
Sierra Leone [95, 96].
Funding is critical in responding to large and severe outbreaks of the nature of the West 
African Ebola outbreak. Many countries specifically donated to bring this health event 
under control. The US was the first country to donate to the Ebola response, then came the 
UK, Germany and the World Bank. The U.S. government allocated approximately $2.369 
billion for Ebola response activities, including $798 million to CDC, $632 million to the 
Department of Defense, and $939 to the U.S. Agency for International Development. In 
addition to providing personnel, technical expertise, and resources to the response, these 
funds established three new emergency operations centers in Guinea, Liberia, and Sierra 
Leone [97]. Charity organizations, foundations and individuals also contributed financially 
to the global Ebola response.
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6. Conclusion
EVD remains a global health problem. Identified in 1976 in Zaire (now Democratic Republic 
of Congo), Ebola is a highly contagious virus that manifests itself in the form of a hemorrhagic 
fever. The natural reservoir of the virus is fruit bat, which can contaminate humans directly 
or indirectly, through primates. Human-to-human transmission occurs through body fluids 
such as blood, stools, saliva, etc. The most severe Ebola outbreak began in December 2013 in 
south-eastern Guinea (West Africa) and extended to Liberia and Sierra Leone. The virus also 
affected Nigeria, Senegal, and Mali and even beyond the African continent (USA, UK, and 
Italy); at the end of October 2014, there were nearly 5000 deaths caused by the EVD. The 
latest outbreak ended on 2 July 2017, in the Likati Health Zone in Bas-Uélé Province of the 
Democratic Republic of the Congo (DRC).
Aside the high CFR associated with EVD (between 25 and 90%), a worrying phenomenon has 
been the continuous loss of already inadequate critical clinical and support workforce to the 
disease in outbreak and response settings. In low resource settings, the challenge has been the 
inability of the ministries of health to provide the adequate medical consumables necessary 
to protect the health workers and to ensure proper infection control practices. While health 
staff in these regions are gaining more knowledge and experience in dealing with occasional 
outbreaks, these logistical challenges considerably hinder their practice and further expose 
them to infections.
Though there is no effectively established drug for the treatment of EVD, recent advance-
ment in vaccine development present a ray of hope that EVD could potentially be a vaccine 
preventable disease.
It is noted that Ebola outbreaks have the potential to escalate in resource-challenged regions 
with non-existent or very basic health infrastructure, poor road networks making the commu-
nities hard-to-reach and the primary co-existence or apparent contact with reservoirs. In the 
instance of the 2014 West African outbreak which was reported in densely populated urban 
centers, the disease spread rapidly due to weak health systems, inadequate infection pre-
vention and control measures and non-responsive disease surveillance systems. Partnership 
between international organizations and ministries of health of Ebola endemic countries 
therefore become crucial to prevent, detect and appropriately respond to surges of Ebola 
among populations. This may be done through direct support to strengthen disease surveil-
lance systems to ensure total coverage of all regions/provinces and districts, strengthening 
event based surveillance to establish early warning systems for disease outbreaks, building 
the capacity of local laboratories and encouraging the formation of a network of laboratories 
within and among neighboring countries while prioritizing infection prevention and control 
measures. Considering the ease of global spread of this disease in light of the rapid migratory 
patterns in recent years, the burden of preventing and controlling this disease rests on the 
Public health authorities of all countries over the world and their partners to work towards:
• Organizing community education campaigns designed to give more details on the viral 
nature of the EVD.
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• Increase awareness through health education of the population through campaigns about 
EVD with particular attention to: hygienic measures, cooking of bush meat as long as pos-
sible, avoiding coming into contact with the biological fluids from persons suspected or 
diagnosed with a hemorrhagic fever.
• Communities affected by the Ebola virus must inform the population of the measures tak-
en to contain the outbreak, including safe, dignified burial and funeral practices. People 
who have died from this infection must be buried quickly and without excessive risk to 
those who carry out the burial.
• Inform the population about the physio-pathological aspect of the virus in order to reduce 
rumors and false beliefs about the disease.
• Expanding training of qualified people for better management of the outbreak, and in-
crease supply of medical materials to isolated rural areas.
• Establishing structures for early detection of any future outbreaks. Motivating the health 
care professionals, especially those working in the zone with previous Ebola outbreaks.
• For travelers, it is important to impose quarantine to any person suspected or diagnosed 
with EVD.
• Laboratory research should be carried out in biosafety. Procedures on sterilization and 
decontamination must be rigorously applied to avoid laboratory contamination.
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